UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
1-12830
SEC FILE NUMBER
09066L-10-5
CUSIP NUMBER
(Check
One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [x] Form 10-Q [ ] Form 10-D [ ]
Form N-SAR
[ ] Form
N-CSR
For
Period Ended: September 30, 2008
[ ]
Transition Report on Form 10-K
[ ]
Transition Report on Form 20-F
[ ]
Transition Report on Form 11-K
[ ]
Transition Report on Form 10-Q
[ ]
Transition Report on Form N-SAR
[ ]
Transition Report on Form N-CSR
For the
Transition Period Ended:
Nothing
in this form shall be construed to imply that the Commission has verified any
information contained herein.
If the
notification relates to a portion of the filing checked above, identify the
Item(s) to which the notification relates:
PART
IBREGISTRANT
INFORMATION
BioTime,
Inc.
Full name
of Registrant
Address
of Principal Executive Offices
1301
Harbor Bay Parkway, Suite 100
(Street
and Number)
Alameda,
California 94502
(City,
State, and Zip Code)
PART
II-RULES 12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate) [x]
(a) The
reasons described in Part III of this form could not be eliminated without
unreasonable effort or expense.
(b) The subject
annual report, semi-annual report, transition report on Form 10-K, Form 20-F,
Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or
before the fifteenth calendar day following the prescribed due date, or the
subject quarterly report or transition report on Form 10-Q or subject
distribution report on Form10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date; and
(c) The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been
attached if applicable.
PART
IIIBNARRATIVE
BioTime could not file its Quarterly
Report on Form 10-Q for the three months ended September 30, 2008 within the
prescribed period because in order to complete its financial statements certain
documentation is required from its lenders, who are located in various parts of
the country, concerning the extension of BioTime’s line of
credit. Some of the necessary documentation was not received by the
prescribed due date of the Form 10-Q.
BioTime expects that it will be able to
file its Form 10-Q by the fifth calendar day following the prescribed due
date.
PART
IVBOTHER
INFORMATION
|
(1)
|
Name
and telephone number of person to contact in regard to this
notification:
|
Steven A. Seinberg, Chief
Financial
Officer
(510) 521-3390
(Name) (Area
Code) (Telephone
Number)
(2) Have
all other periodic reports required under Section 13 or 15(d) of the Securities
Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that the registrant was
required to file such report(s) been filed? If answer is no, identify
reports(s) [x] Yes [ ] No
(3) Is
it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflect by the earnings
statements to be included in the subject report or portion thereof? [ ] Yes [x]
No
BioTime,
Inc. has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
BIOTIME, INC.
|
Date: November
14, 2008
|
By
_/s/ Steven A.
Seinberg____
|
| |
Steven
A. Seinberg, |
| |
Chief
Financial Officer |